GeneFerm Biotechnology Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	28.86	-22.53	124.62	93.45	57.41
Depreciation & Amortization	74.48	79.36	73.49	50.03	45.36
Loss (Gain) From Sale of Assets	0.28	-0.02	-0.01	0.11	-0.04
Provision & Write-off of Bad Debts	-0.04	-1.09	-0.43	-0.72	1.44
Other Operating Activities	0.05	-34.31	5.11	1.06	24.97
Change in Accounts Receivable	-3.94	11.92	-6.86	4.51	-33.4
Change in Inventory	-18.82	-15.47	-9.38	-30.94	-8.14
Change in Accounts Payable	3.64	3.94	-3.23	0.19	-0.43
Change in Unearned Revenue	11.46	6.71	-1.85	-0.67	1.33
Change in Other Net Operating Assets	3.35	-20.42	8.85	5.4	23.72
Operating Cash Flow	99.31	8.09	190.31	122.43	112.23
Operating Cash Flow Growth	1127.59%	-95.75%	55.44%	9.09%	98.93%
Capital Expenditures	-23.42	-22.4	-69.94	-278.18	-144.88
Sale of Property, Plant & Equipment	0.21	0.03	0.01	0.04	0.04
Sale (Purchase) of Intangibles	-	-0.3	-1.46	-0.24	-0.72
Other Investing Activities	0.63	-0.16	0.78	-1.95	0.31
Investing Cash Flow	-22.59	-22.83	-70.62	-280.33	-145.26
Short-Term Debt Issued	50	80	240	45	-
Long-Term Debt Issued	120	171	-	-	5
Total Debt Issued	170	251	240	45	5
Short-Term Debt Repaid	-50	-120	-245	-	-
Long-Term Debt Repaid	-38.94	-31.7	-32.68	-285.33	-74.17
Total Debt Repaid	-88.94	-151.7	-277.68	-285.33	-74.17
Net Debt Issued (Repaid)	81.06	99.3	-37.68	-240.33	-69.17
Issuance of Common Stock	-	-	-	-	297.36
Common Dividends Paid	-	-82.92	-62.19	-41.46	-3.39
Financing Cash Flow	81.06	16.38	-99.87	-281.79	224.81
Foreign Exchange Rate Adjustments	0.02	0.65	-0.36	0.76	-0.19
Net Cash Flow	157.81	2.3	19.46	-438.92	191.59
Free Cash Flow	75.89	-14.31	120.37	-155.74	-32.65
Free Cash Flow Margin	11.21%	-2.74%	15.17%	-24.57%	-6.25%
Free Cash Flow Per Share	1.84	-0.34	2.89	-3.66	-0.70
Cash Interest Paid	6.15	4.42	4.15	2.74	1.23
Cash Income Tax Paid	0.16	34.43	20.28	20.86	-1.97
Levered Free Cash Flow	65.09	-14.32	67.65	-169.4	-49.01
Unlevered Free Cash Flow	68.98	-11.55	70.26	-167.01	-44.44
Change in Working Capital	-4.32	-13.32	-12.47	-21.5	-16.91

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.